您好,欢迎来到皮书数据库!
热点推荐: 双循环
更多>> 课题组动态
更多>> 皮书作者
谢伏瞻
    中国社会科学院学部委员,学部主席团主席,研究员,博士生导师。历任中国社会科学院院长、党组书记,国务院发展中心副主... 详情>>
蔡 昉
    中国社会科学院国家高端智库首席专家,学部委员,学部主席团秘书长,研究员,博士生导师。先后毕业于中国人民大学、中国... 详情>>
李培林
    男,汉族,出生于1955年5月,山东济南人,博士,研究员,全国人民代表大会社会建设委员会副主任委员,中国社会科学... 详情>>

    我国药用辅料的现状及管理对策研究

    摘要

    药用辅料是药品不可或缺的重要组成部分,其质量和安全性直接影响药品的质量。近年来,几次重大药品安全性事件暴露了药用辅料的风险,对药用辅料的监管显得越来越紧迫。长期以来,我国对于药用辅料尚没有形成专门的注册监管办法。因此,需要从源头上控制药用辅料给药品带来的安全性问题。本研究通过对国内及上海市药用辅料的生产、已批准药用辅料的注册、国内辅料的质量标准、药品生产企业对辅料的使用,以及监管中存在问题的调研与分析,借鉴国际上相关的先进监管办法,提出加强药用辅料监管的建议和对策。

    <<
    >>

    Abstract

    Pharmaceutical excipients are essential ingredients for drug products. The quality and safety of excipients directly impact the safety and efficacy of drug products. Some drug safety events in recent years have revealed the safety risks induced by pharmaceutical excipients. It becomes more and more urgent to reinforce the administration of pharmaceutical excipients. However,there’s no specific regulation on administration of pharmaceutical excipients yet. In spite of the strengthen of routine supervision,it is worth to discuss in depth how to combine the risk management philosophy during the approval process,therefore to control the safety risks brought by pharmaceutical excipients at the source. Through the comparisive study on the administration of pharmaceutical excipients between home and abroad,as well as the investigation on the status quo of manufacture and application of excipients at local and other provinces,this research aims to analyse the practical problems existed currently and figure out countermeasures to improve the local administration of excipients,hence to better control the safety risk from excipient and facilitate the development of pharmaceutical industry. This research also gives recommendations on risk management and new registration approaches for pharmaceutical excipient.

    <<
    >>
    作者简介
    程国樑:程国樑,上海市食品药品监督管理局,课题负责人
    王方敏:课题联系人:王方敏,联系方式是wangfm@smda.gov.cn。
    高敏洁:
    朱娟:
    张清:
    李杰:
    吴浩:
    周坛树:
    阮秀芳:
    <<
    >>
    相关报告